Characterization of intracellular and extracellular vaccinia virus variants: N1-isonicotinoyl-N2-3-methyl-4-chlorobenzoylhydrazine interferes with cytoplasmic virus dissemination and release.
about
An orally bioavailable antipoxvirus compound (ST-246) inhibits extracellular virus formation and protects mice from lethal orthopoxvirus ChallengePoxvirus pathogenesisMultiple phosphatidylinositol 3-kinases regulate vaccinia virus morphogenesisEnvelope formation is blocked by mutation of a sequence related to the HKD phospholipid metabolism motif in the vaccinia virus F13L proteinThe envelope protein encoded by the A33R gene is required for formation of actin-containing microvilli and efficient cell-to-cell spread of vaccinia virus.Analysis of a vaccinia virus mutant expressing a nonpalmitylated form of p37, a mediator of virion envelopment.Vaccinia virus F13L protein with a conserved phospholipase catalytic motif induces colocalization of the B5R envelope glycoprotein in post-Golgi vesiclesMutagenesis of phospholipase D defines a superfamily including a trans-Golgi viral protein required for poxvirus pathogenicity.Phospholipase D: enzymology, functionality, and chemical modulationThe cytoplasmic and transmembrane domains of the vaccinia virus B5R protein target a chimeric human immunodeficiency virus type 1 glycoprotein to the outer envelope of nascent vaccinia virions.The A34R glycoprotein gene is required for induction of specialized actin-containing microvilli and efficient cell-to-cell transmission of vaccinia virusOrthopoxvirus targets for the development of antiviral therapies.Dissociation of progeny vaccinia virus from the cell membrane is regulated by a viral envelope glycoprotein: effect of a point mutation in the lectin homology domain of the A34R gene.Deletion of the vaccinia virus B5R gene encoding a 42-kilodalton membrane glycoprotein inhibits extracellular virus envelope formation and dissemination.Role of cell-associated enveloped vaccinia virus in cell-to-cell spreadA mutation in the gene encoding the vaccinia virus 37,000-M(r) protein confers resistance to an inhibitor of virus envelopment and releaseExtracellular vaccinia virus formation and cell-to-cell virus transmission are prevented by deletion of the gene encoding the 37,000-Dalton outer envelope protein.Localization and fine structure of a vaccinia virus gene encoding an envelope antigenOrthopoxvirus targets for the development of new antiviral agents.Retrograde Transport from Early Endosomes to the trans-Golgi Network Enables Membrane Wrapping and Egress of Vaccinia Virus Virions.Membrane fusion during poxvirus entry.Functional analysis of vaccinia virus B5R protein: essential role in virus envelopment is independent of a large portion of the extracellular domain.Identification and characterization of an extracellular envelope glycoprotein affecting vaccinia virus egress.Characterization of a molluscum contagiosum virus homolog of the vaccinia virus p37K major envelope antigen.Golgi-derived membranes that contain an acylated viral polypeptide are used for vaccinia virus envelopment.The vaccinia virus F13L YPPL motif is required for efficient release of extracellular enveloped virus.A phosphorylated basic vaccinia virion polypeptide of molecular weight 11,000 is exposed on the surface of mature particles and interacts with actin-containing cytoskeletal elements.Interaction between vaccinia virus extracellular virus envelope A33 and B5 glycoproteins.A novel immunogold cryoelectron microscopic approach to investigate the structure of the intracellular and extracellular forms of vaccinia virus.
P2860
Q24535956-E64BED86-08A1-4768-BF1D-417AD79D0E9AQ24634729-A656E296-7B04-4818-8AB7-4E1F640152F4Q27325801-9FA8485A-1E0B-42D0-AD0B-01A69877C493Q33640531-BD76AB98-E5D2-4C84-B344-42E14C00BB56Q33782803-B32F8865-A16E-45F4-89AF-B61A1D4F5D1CQ33784474-733DE135-6B96-419F-B2EE-1336D966616BQ33852860-4D50DDE4-8E37-4B7D-818C-FB33AC5F0917Q33887155-97129D1F-7C09-4EC4-80EC-BF17BEBEEF67Q35599714-F447682B-2530-4E19-862B-987AD673ED1AQ35881351-74ED97B5-DE4B-4662-94E0-067B31EB27ABQ35883712-3107F0EC-493E-4BDC-B891-71E0D1F58C52Q36074391-728E3072-7EEA-4A77-B930-EC52451B1B63Q36647697-E5625741-C68B-47FB-93C2-0978044B6D90Q36651113-274F8032-51D0-44F2-8A07-756E1C08AB0DQ36698801-E23EDB07-5350-44BF-8AF2-21D8C04DE780Q36700431-36C87153-8580-44AC-A8C4-688F4BBE5468Q36820928-0D4C18F6-823D-4780-AA20-DDBADD3F13AEQ36863438-497120B3-E9DF-4C1D-93F8-D260A024CCABQ37173398-3FEDD9FF-441B-46F4-AA73-9043CC0CD862Q37252890-90B21757-A868-4792-9374-74C9C9ED3F7AQ38899115-5A23366F-4549-41D8-9F42-E987632BF6F2Q39577168-A88CA5C1-B2F0-4717-8E29-4040B4C98E6BQ40064533-7C9A5C1D-D0D7-4DFC-A9E7-A59F9DC35C7EQ40066985-1BB6BF6A-290F-40D9-90F2-23BFEF708F7EQ40136590-CE5F8454-4A88-45F2-B34D-196FC8B4AAF0Q40138053-8AFDB7CE-D334-4F41-8236-281C8E9246C7Q40142793-4EDEB594-0F60-4316-A833-91002E0F2C06Q40243102-08654C15-1DD2-453C-8266-6F465548626AQ41064981-D0D29BE3-D2C6-4FFB-A4A4-5C72198BC8A8
P2860
Characterization of intracellular and extracellular vaccinia virus variants: N1-isonicotinoyl-N2-3-methyl-4-chlorobenzoylhydrazine interferes with cytoplasmic virus dissemination and release.
description
1981 nî lūn-bûn
@nan
1981 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1981 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1981年の論文
@ja
1981年論文
@yue
1981年論文
@zh-hant
1981年論文
@zh-hk
1981年論文
@zh-mo
1981年論文
@zh-tw
1981年论文
@wuu
name
Characterization of intracellu ...... rus dissemination and release.
@ast
Characterization of intracellu ...... rus dissemination and release.
@en
type
label
Characterization of intracellu ...... rus dissemination and release.
@ast
Characterization of intracellu ...... rus dissemination and release.
@en
prefLabel
Characterization of intracellu ...... rus dissemination and release.
@ast
Characterization of intracellu ...... rus dissemination and release.
@en
P2093
P2860
P1433
P1476
Characterization of intracellu ...... rus dissemination and release.
@en
P2093
P2860
P304
P407
P577
1981-09-01T00:00:00Z